Atara Biotherapeutics is a leading off-the-shelf, allogeneic T-cell immunotherapy company developing novel treatments for patients with cancer, autoimmune and viral diseases. Our commitment is to make every effort to support patients in need of treatment options.

More information about Atara’s ongoing clinical studies can be found here.

We also recognize our clinical studies may not be available to all patients who have life threatening diseases and no satisfactory treatment alternatives.  Learn more about Atara’s expanded access programs and compassionate use policy here.